Drug DescriptionIndicationsDosageSide EffectsDrug InteractionsWarningsPrecautionsOverdosageContraindicationsClinical PharmacologyMedication Guide
Side Effects Center
ADVERTISEMENT
Atropine
Table of Contents
Drug Description
Indications
Dosage
Side Effects
Drug Interactions
Warnings
Precautions
Overdosage
Contraindications
Clinical Pharmacology
Medication Guide
Side Effects Center
Drug Description
ATROPINE SULFATE Injection, USP
0.1 mg/mI (Adult)
0.05 mg/mL (Pediatric)
ABBOJECT® Unit of Use Syringe
Atropine Sulfate Injection, USP is a sterile, nonpyrogenic isotonic solution of atropine sulfate monohydrate in water for injection with sodium chloride sufficient to render the solution isotonic. It is administered parenterally by subcutaneous, intramuscular or intravenous injection.
Each milliliter (mL) contains atropine sulfate, monohydrate 0.1 mg (adult strength) or 0.05 mg (pediatric strength), and sodium chloride, 9 mg. May contain sodium hydroxide and/or sulfuric acid for pH adjustment 0.308 mOsmol/mL (calc.). pH 4.2 (3.0 to 6.5).
The solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection. When smaller doses are required the unused portion should be discarded.
Atropine Sulfate Injection is a parenteral anticholinergic agent and muscarinic antagonist.
Atropine Sulfate, USP is chemically designated 1a H, 5a H-Tropan-3-a ol (±)-tropate(ester), sulfate (2:1) (salt) monohydrate, (C17H23NO3)2 • H2SO4 • H2O, colorless crystals or white crystalline powder very soluble in water. It has the following structural formula:
Atrop
Atropine, a naturally occurring belladonna alkaloid, is a racemic mixture of equal parts of d- and 1-hyocyamine, whose activity is due almost entirely to the levo isomer of the drug.
Sodium Chloride, USP is chemically designated NaCI, a white crystalline powder freely soluble in water.
The syringe is molded from a specially formulated polypropylene. Water permeates from inside the container at an extremely slow rate which will have an insignificant effect on solution concentration over the expected shelf life. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the syringe material.
PHRONESIS MEDICARE INTERNATIONAL BLS overview for infant Basic life support (BLS) is a basic level of medical care used to help sustain a person who is experiencing cardiac arrest or respiratory failure, until they can be given full medical care by an advanced responder. BLS can be used in any scenario where breathing or heartbeat has been compromised, such as drowning, heart attack, or severe shock (eg, severe loss of blood). BLS is more comprehensive than CPR alone, since it covers additional steps that are not expected from a layperson, as well as techniques for working with other rescuers. The techniques used for BLS vary slightly depending on whether the victim is an adult, child, or infant. This module explains the techniques and procedure for performing BLS on an infant. The adult and child procedures are covered in separate modules. Note: The term 'infant' in this context refers to neonates outside the delivery room setting, up to 12 months old. Children 12 month
Comments